Elijah Saunders

3.2k total citations
57 papers, 2.4k citations indexed

About

Elijah Saunders is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elijah Saunders has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 19 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elijah Saunders's work include Blood Pressure and Hypertension Studies (30 papers), Hormonal Regulation and Hypertension (12 papers) and Sodium Intake and Health (6 papers). Elijah Saunders is often cited by papers focused on Blood Pressure and Hypertension Studies (30 papers), Hormonal Regulation and Hypertension (12 papers) and Sodium Intake and Health (6 papers). Elijah Saunders collaborates with scholars based in United States, Australia and Bahamas. Elijah Saunders's co-authors include Alan N. Unger, Robin P. Hertz, John M. Flack, Matthew R. Weir, Keith C. Ferdinand, Elizabeth Ofili, William H. Frishman, George L. Bakris, Fadia T. Shaya and C. Daniel Mullins and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Elijah Saunders

55 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elijah Saunders United States 22 1.5k 791 383 353 280 57 2.4k
N. Poulter United Kingdom 18 2.2k 1.4× 709 0.9× 433 1.1× 300 0.8× 505 1.8× 57 3.3k
Ellen Burgess Canada 36 1.2k 0.8× 605 0.8× 518 1.4× 248 0.7× 442 1.6× 95 4.0k
Jan Basile United States 28 1.8k 1.2× 949 1.2× 241 0.6× 377 1.1× 548 2.0× 150 3.0k
Ingrid Os Norway 36 1.4k 1.0× 737 0.9× 333 0.9× 269 0.8× 466 1.7× 169 3.6k
Brian Rayner South Africa 31 951 0.6× 1.0k 1.3× 306 0.8× 262 0.7× 482 1.7× 139 3.3k
J.L. Llisterri Spain 24 1.8k 1.2× 470 0.6× 197 0.5× 260 0.7× 476 1.7× 130 2.3k
Dena Ettehad United Kingdom 4 1.7k 1.1× 464 0.6× 282 0.7× 387 1.1× 342 1.2× 4 2.4k
Shantha Madhavan United States 24 1.4k 1.0× 554 0.7× 504 1.3× 737 2.1× 248 0.9× 40 2.9k
Amit Kiran United Kingdom 16 1.8k 1.2× 464 0.6× 296 0.8× 387 1.1× 619 2.2× 26 3.0k
Stacie L. Daugherty United States 29 2.4k 1.6× 632 0.8× 325 0.8× 418 1.2× 617 2.2× 80 3.6k

Countries citing papers authored by Elijah Saunders

Since Specialization
Citations

This map shows the geographic impact of Elijah Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elijah Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elijah Saunders more than expected).

Fields of papers citing papers by Elijah Saunders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elijah Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elijah Saunders. The network helps show where Elijah Saunders may publish in the future.

Co-authorship network of co-authors of Elijah Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of Elijah Saunders. A scholar is included among the top collaborators of Elijah Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elijah Saunders. Elijah Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Onukwugha, Eberechukwu, et al.. (2012). A qualitative study to identify reasons for discharges against medical advice in the cardiovascular setting. BMJ Open. 2(4). e000902–e000902. 21 indexed citations
2.
Shaya, Fadia T., et al.. (2012). Social Networks Help Control Hypertension. Journal of Clinical Hypertension. 15(1). 34–40. 20 indexed citations
3.
Onukwugha, Eberechukwu, et al.. (2011). Readmissions After Unauthorized Discharges in the Cardiovascular Setting. Medical Care. 49(2). 215–224. 13 indexed citations
7.
Flack, John M., Ronald G. Victor, Karol E. Watson, et al.. (2008). Improved Attainment of Blood Pressure and Cholesterol Goals Using Single-Pill Amlodipine/Atorvastatin in African Americans: The CAPABLE Trial. Mayo Clinic Proceedings. 83(1). 35–45. 43 indexed citations
8.
Saunders, Elijah, et al.. (2007). The Efficacy and Tolerability of Nebivolol in Hypertensive African American Patients. Journal of Clinical Hypertension. 9(11). 866–875. 58 indexed citations
9.
Shaya, Fadia T., Anna Gu, & Elijah Saunders. (2007). Metabolic syndrome prevalence in an urban African American population. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 1(3). 151–157. 4 indexed citations
10.
Stewart, David, et al.. (2006). Hypertension in black Americans as a special population: Why so special?. Current Cardiology Reports. 8(6). 405–410. 8 indexed citations
11.
Sowers, James R., Joel M. Neutel, Elijah Saunders, et al.. (2006). Antihypertensive Efficacy of Irbesartan/HCTZ in Men and Women With the Metabolic Syndrome and Type 2 Diabetes. Journal of Clinical Hypertension. 8(7). 470–480. 36 indexed citations
12.
Neutel, Joel M., Elijah Saunders, George L. Bakris, et al.. (2005). The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial. Journal of Clinical Hypertension. 7(10). 578–586. 65 indexed citations
13.
Saunders, Elijah. (2004). Managing Hypertension in African‐American Patients. Journal of Clinical Hypertension. 6(s4). 19–25. 8 indexed citations
14.
Saunders, Elijah & James R. Gavin. (2003). Blockade of the Renin‐Angiotensin System in African Americans With Hypertension and Cardiovascular Disease. Journal of Clinical Hypertension. 5(1). 12–17. 9 indexed citations
15.
Flack, John M., Suzanne Oparil, J. Howard Pratt, et al.. (2003). Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. Journal of the American College of Cardiology. 41(7). 1148–1155. 183 indexed citations
16.
Saunders, Elijah. (1991). The safety and efficacy of terazosin in the treatment of essential hypertension in blacks. American Heart Journal. 122(3). 936–942. 3 indexed citations
17.
Winters, William L., Henry D. McIntosh, Melvin D. Cheitlin, et al.. (1990). Task force II: The relation of cardiovascular specialists to patients, other physicians and physician-owned organizations. Journal of the American College of Cardiology. 16(1). 11–16. 3 indexed citations
18.
DeQuattro, Vincent, Janice G. Douglas, Laura P. Svetkey, et al.. (1990). Evaluation of the Clinical Pharmacology of Nilvadipine in Patients with Mild to Moderate Essential Hypertension. The Journal of Clinical Pharmacology. 30(5). 425–437. 4 indexed citations
19.
Saunders, Elijah. (1990). Tailoring treatment to minority patients. The American Journal of Medicine. 88(3). S21–S23. 21 indexed citations
20.
Weir, Matthew R., et al.. (1987). Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension. The American Journal of Cardiology. 60(17). 36–41. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026